Biomm SA
BOVESPA:BIOM3

Watchlist Manager

Biomm SA

BOVESPA:BIOM3

Watchlist

Dividends

Discount Rate

Price: 8.9 BRL -0.56%

Market Cap: 1.1B BRL

Have any thoughts about
Biomm SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 8.9 BRL

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

BIOM3 Alert

Biomm SA

8.9

-0.05 (-0.56%)

52 Week Range	4.15 20.19
Price Target

We'll email you a reminder when the closing price reaches BRL.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Biomm SA

What unique competitive advantages
does Biomm SA hold over its rivals?

What risks and challenges
does Biomm SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Biomm SA.

What unique competitive advantages
does Biomm SA hold over its rivals?

What risks and challenges
does Biomm SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biomm SA.

Provide P/S
for Biomm SA.

Provide P/E
for Biomm SA.

Provide P/OCF
for Biomm SA.

Provide P/FCFE
for Biomm SA.

Provide P/B
for Biomm SA.

Provide EV/S
for Biomm SA.

Provide EV/GP
for Biomm SA.

Provide EV/EBITDA
for Biomm SA.

Provide EV/EBIT
for Biomm SA.

Provide EV/OCF
for Biomm SA.

Provide EV/FCFF
for Biomm SA.

Provide EV/IC
for Biomm SA.

Compare the intrinsic valuations
of Biomm SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biomm SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biomm SA compared to its peers.

Compare the P/E ratios
of Biomm SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Biomm SA with its peers.

Analyze the financial leverage
of Biomm SA compared to its main competitors.

Show all profitability ratios
for Biomm SA.

Provide ROE
for Biomm SA.

Provide ROA
for Biomm SA.

Provide ROIC
for Biomm SA.

Provide ROCE
for Biomm SA.

Provide Gross Margin
for Biomm SA.

Provide Operating Margin
for Biomm SA.

Provide Net Margin
for Biomm SA.

Provide FCF Margin
for Biomm SA.

Show all solvency ratios
for Biomm SA.

Provide D/E Ratio
for Biomm SA.

Provide D/A Ratio
for Biomm SA.

Provide Interest Coverage Ratio
for Biomm SA.

Provide Altman Z-Score Ratio
for Biomm SA.

Provide Quick Ratio
for Biomm SA.

Provide Current Ratio
for Biomm SA.

Provide Cash Ratio
for Biomm SA.

What is the historical Revenue growth
over the last 5 years for Biomm SA?

What is the historical Net Income growth
over the last 5 years for Biomm SA?

What is the current Free Cash Flow
of Biomm SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biomm SA.

EV/GP
Enterprise Value to Gross Profit

37.1

Current

33.1

Median

9.2

Industry

Higher than median

Higher than industry value

All Countries

Forward Multiples

			Market Cap	EV/GP
BR		Biomm SA BOVESPA:BIOM3	1.1B BRL	37.1
US		Abbvie Inc NYSE:ABBV	334.6B USD	10.4
US		Amgen Inc NASDAQ:AMGN	172.7B USD	11.3
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	125.3B USD	13.4
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	111.4B USD	8.9
US		Gilead Sciences Inc NASDAQ:GILD	108.2B USD	5.9
US	E	Epizyme Inc F:EPE	94.1B EUR	2 547.4
AU		CSL Ltd ASX:CSL	145.3B AUD	13.9
US	S	Seagen Inc F:SGT	39.3B EUR	23.9
US		Alnylam Pharmaceuticals Inc NASDAQ:ALNY	38.1B USD	17.9
KY		Beigene Ltd SSE:688235	248.5B CNY	12.7


BR		Biomm SA BOVESPA:BIOM3	Average EV/GP: 245.7 37.1
US		Abbvie Inc NYSE:ABBV	10.4
US		Amgen Inc NASDAQ:AMGN	11.3
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	13.4
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	8.9
US		Gilead Sciences Inc NASDAQ:GILD	5.9
US	E	Epizyme Inc F:EPE	2 547.4
AU		CSL Ltd ASX:CSL	13.9
US	S	Seagen Inc F:SGT	23.9
US		Alnylam Pharmaceuticals Inc NASDAQ:ALNY	17.9
KY		Beigene Ltd SSE:688235	12.7

EV/GP Forward Multiples

Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/GP

N/A

2-Years Forward

EV/GP

N/A

3-Years Forward

EV/GP

N/A

Biomm SA
BOVESPA:BIOM3

EV/GP
Enterprise Value to Gross Profit

EV/GP Forward Multiples

See Also

Company

Help

Tools

Stocks

Biomm SA BOVESPA:BIOM3

EV/GP Enterprise Value to Gross Profit

EV/GP Forward Multiples

See Also

Company

Help

Tools

Stocks

Biomm SA
BOVESPA:BIOM3

EV/GP
Enterprise Value to Gross Profit